|
|
|
Sunday, March 8, 2009 — 1:30 PM, Convention Center 306
|
- Molecular Pathology for the Practicing Pathologist
|
|
Moderators:
|
Maria J. Merino, National Cancer Institute, Bethesda, MD and Julian Sanz-Ortega, Hospital Clinico San Carlos, Madrid, Spain
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Mark Stoler is a consultant for Merck, Qiagen, Hologic, Roche, Gen-Probe and Ventana Medical. The other speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| 1:30 | The Future of the Pap Smear Screening in the Era of Molecular Diagnostics and Vaccines - Mark H. Stoler, University of Virginia Health Science Center, Charlottesville, VA |
| 2:15 | Recent Advances in the Molecular Pathology of Lung Cancer: Role of EGFR and KRAS Mutation Testing in Treatment Selection - Marc Ladanyi, Memorial Sloan-Kettering Cancer Center, New York, NY |
| 3:00 | Break |
| 3:30 | The Role of miRNAs in Cancer Diagnosis and Prognosis: No Small Matter - Marina Nikiforova, University of Pittsburgh, Pittsburgh, PA |
| 4:15 | Integrating Morphology and Molecular Pathology to Manage the Diagnosis and Treatment of Colon Cancer - Julian Sanz-Ortega, Hospital Clinico San Carlos, Madrid, Spain |
|
The ASIP Education Committee reviewed the participant critiques from 2005 - 2008. The 2008 educational objective was to demonstrate how advances in the understanding of pathogenesis can be applied to surgical pathology practice. The Committee agreed that this is a continuing educational need and should again be the focus of the 2009 symposia with greater emphasis on the impact of molecular pathology this year. Organizers who are well versed in experimental molecular pathology and diagnostic surgical pathology were chosen and they searched the most recent literature for the most important advances in molecular pathology to determine topics for the 2009 companion meeting. Objective: Pathologists need new strategies to solve key differential diagnostic problems for tumors. The objective of the ASIP Companion Meeting is to demonstrate how advances in the understanding of molecular pathogenesis and molecular diagnostic techniques can be applied to surgical pathology practice. The goal is to inform attendees about newly discovered molecular mechanisms of disease pathogenesis and new molecular technologies that can lead to better diagnostic and prognostic tests and pathologists’ recommendations for appropriate therapies.
|
|
|
|
